Cme (CME) Common Equity (2016 - 2026)
Cme has reported Common Equity over the past 18 years, most recently at $26.6 billion for Q1 2026.
- Quarterly Common Equity rose 468.05% to $26.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $26.6 billion through Mar 2026, up 468.05% year-over-year, with the annual reading at $28.7 billion for FY2025, 8.46% up from the prior year.
- Common Equity was $26.6 billion for Q1 2026 at Cme, down from $28.7 billion in the prior quarter.
- Over five years, Common Equity peaked at $28.7 billion in Q4 2025 and troughed at -$95.0 million in Q2 2024.
- The 5-year median for Common Equity is $5.3 billion (2025), against an average of $12.2 billion.
- Biggest five-year swings in Common Equity: crashed 4220.0% in 2024 and later soared 65355.32% in 2025.
- Tracing CME's Common Equity over 5 years: stood at -$900000.0 in 2022, then soared by 6988.89% to $62.0 million in 2023, then skyrocketed by 42620.81% to $26.5 billion in 2024, then rose by 8.46% to $28.7 billion in 2025, then dropped by 7.34% to $26.6 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods came in at $26.6 billion, $28.7 billion, and $28.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.